Aligos therapeutics appoints laura kavanaugh as vice president, head of legal

South san francisco, calif., may 20, 2025 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the appointment of laura kavanaugh, jd as vice president, head of legal, effective immediately.
ALGS Ratings Summary
ALGS Quant Ranking